ArticleScientific reports2025
A novel two-stage feature selection method based on random forest and improved genetic algorithm for enhancing classification in machine learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Toward Interpretable Voice-Based Parkinson's Disease Screening via Joint Transfer Function-Feature-Classifier-Ensemble Selection.Bioengineering (Basel, Switzerland) · 2026Article
- Construction of a prediction model for depression risk in elderly patients with chronic obstructive pulmonary disease based on machine learning algorithms and analysis of influencing factors.Scientific reports · 2026Article
- Machine learning-driven clinical decision support for liver cirrhosis: a gut microbiome-based web prediction model with explainable AI integration.BMC gastroenterology · 2026Article
- Exploring the toxicological impact of N-nitrosodimethylamine (NDMA) exposure on bladder urothelial carcinoma (BLCA) through network toxicology, machine learning, and multi-dimensional bioinformatics analysis.Discover oncology · 2026Article
- Article
- Cheminformatics and Machine Learning-Driven QSAR Analysis of SPHK2 Inhibitors for Anticancer Drug Design.Current medicinal chemistry · 2026Article
- A relevant feature combination assisted bi-level evolutionary multi-objective algorithm for feature selection in classification.Scientific reports · 2025Article
- Detecting CSF-validated Alzheimer's disease from spontaneous speech in German: an interpretable end-to-end machine-learning framework.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
The data acquisition methods are becoming increasingly diverse and advanced, leading to higher data dimensions, blurred classification boundaries, and overfitting datasets, affecting machine learning models' accuracy. Many studies have sought to improve model performance through feature selection. However, a single feature selection method has incomplete, unstable, or time-consuming shortcomings. Combining the advantages of various feature selection methods can help overcome these defects. This paper proposes a two-stage feature selection method based on random forest and improved genetic algorithm. First, the importance scores of the random forest are calculated and ranked, and the features are preliminarily eliminated according to the scores, reducing the time complexity of the subsequent process. Then, the improved genetic algorithm is used to search for the global optimal feature subset further. This process introduces a multi-objective fitness function to guide the feature subset, minimizing the number of features in the subset while enhancing classification accuracy. This paper also adds an adaptive mechanism and evolution strategy to improve the loss of population diversity and degeneration in the later stages of iteration, thereby enhancing search efficiency. The experimental results on eight UCI datasets show that the proposed method significantly improves classification performance and has excellent feature selection capability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.